About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
EVGN
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Evogene GAAP EPS of -$0.13 beats by $0.01, revenue of $0.58M misses by $0.31M
- Evogene Q4 2023 Earnings Preview
- Casterra signs agreements in Brazil and Africa for castor seed varieties
- Evogene files for $200M mixed shelf offering
- Evogene and Verb Biotics collaborate to advance probiotic innovation
- Evogene GAAP EPS of -$0.08 beats by $0.08, revenue of $3.8M beats by $2.62M
- Evogene Q3 2023 Earnings Preview
- Casterra delivers first shipment of castor seeds to Africa
- Evogene GAAP EPS of -$0.17 in-line, revenue of $0.65M misses by $0.24M
- Evogene Q2 2023 Earnings Preview
- Evogene stock plummets on pricing of $8.5M registered direct offering
- Evogene up 8%, Casterra subsidiary gets $2.2M order for castor seeds
- Evogene unit Casterra signs castor seed supply deal for biofuel production
- Lavie Bio's seed treatment Thrivus gets approval in Canada
- Evogene GAAP EPS of -$0.15, revenue of $0.64M
- Evogene Q1 2023 Earnings Preview
- Evogene subsidiary Lavie Bio appoints Amit Noam as incoming CEO
- Evogene GAAP EPS of -$0.07 beats by $0.13, revenue of $0.66M beats by $0.11M
- Notable earnings before Thursday's open
- Evogene to receive $3.5M from Bayer related to patent portfolio
PEERS
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| May 10, 2018 | -0.21 / - | 366.0K / - |
Beat! |
| March 30, 2018 | -0.24 / -0.74 | 734.0K / 2.45M |
Beat! |
| November 22, 2017 | -0.2 / -0.68 | 748.0K / 8.60M |
Beat! |
| August 10, 2017 | -0.18 / -0.47 | 1.18M / 5.77M | |
| May 17, 2017 | -0.19 / -0.66 | 721.0K / 18.91M |
Beat! |
| July 3, 2014 | -0.65 / -0.41 | 3.85M / 17.58M |
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 | 406 | 417 |
428
|
400
|
136.28K | -1.91% | ||||
| Mar 9 | 414 | 398 |
416
|
394
|
119.19K | 5.08% | ||||
| Mar 8 | 394 | 387 |
402
|
384
|
164.16K | 2.90% | ||||
| Mar 7 | 383 | 390 |
390
|
371
|
126.82K | -1.82% | ||||
| Mar 6 | 390 | 400 |
400
|
386
|
50.45K | -3.3% | ||||
| Mar 3 | 403 | 420 |
430
|
400
|
123.13K | -5.71% | ||||
| Mar 2 | 428 | 411 |
436
|
410
|
171.44K | 4.01% | ||||
| Mar 1 | 411 | 407 |
414
|
397
|
393.49K | 13.22% | ||||
| Feb 28 | 363 | 346 |
372
|
346
|
109.16K | 2.54% | ||||
| Feb 27 | 354 | 360 |
360
|
350
|
108.44K | 2.91% | ||||
| Feb 24 | 344 | 348 |
352
|
338
|
275.79K | -6.11% | ||||
| Feb 23 | 366 | 382 |
382
|
360
|
173.05K | -4.13% | ||||
| Feb 22 | 382 | 385 |
389
|
380
|
99.25K | -1.62% | ||||
| Feb 21 | 389 | 399 |
399
|
386
|
54.60K | -0.66% | ||||
| Feb 20 | 391 | 390 |
396
|
385
|
81.84K | -3.31% | ||||
| Feb 17 | 405 | 403 |
410
|
400
|
66.63K | -0.37% | ||||
| Feb 16 | 406 | 409 |
415
|
401
|
81.64K | -1.22% | ||||
| Feb 15 | 411 | 407 |
420
|
403
|
101.57K | 1.01% | ||||
| Feb 14 | 407 | 418 |
418
|
402
|
222.98K | -2.19% | ||||
| Feb 13 | 416 | 425 |
425
|
405
|
241.40K | -7.45% | ||||